These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15302478)

  • 1. Efficacy and safety of a novel system (NASHA/Dx copolymer using the Implacer device) for treatment of stress urinary incontinence.
    van Kerrebroeck P; ter Meulen F; Larsson G; Farrelly E; Edwall L; Fianu-Jonasson A
    Urology; 2004 Aug; 64(2):276-81. PubMed ID: 15302478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open, multicentre study of NASHA/Dx Gel (Zuidex) for the treatment of stress urinary incontinence.
    Chapple CR; Haab F; Cervigni M; Dannecker C; Fianu-Jonasson A; Sultan AH
    Eur Urol; 2005 Sep; 48(3):488-94. PubMed ID: 15967568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging to evaluate NASHA/Dx gel (Zuidex) for stress urinary incontinence.
    Fianu-Jonasson A; Edwall L; Wiberg MK
    Int J Clin Pract; 2006 Oct; 60(10):1181-6. PubMed ID: 16981962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of stress urinary incontinence with non-animal stabilised hyaluronic acid/dextranomer (NASHA/Dx) gel : An analysis of utility and cost.
    Kobelt G; Fianu-Jonasson A
    Clin Drug Investig; 2006; 26(10):583-91. PubMed ID: 17163292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of transurethral injection of hyaluronic acid/dextranomer (NASHA/Dx gel) for the treatment of stress urinary incontinence (SUI).
    Lone F; Sultan AH; Thakar R
    Int Urogynecol J; 2010 Nov; 21(11):1359-64. PubMed ID: 20571764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy of NASHA Dx injection therapy for treatment of fecal incontinence.
    Mellgren A; Matzel KE; Pollack J; Hull T; Bernstein M; Graf W;
    Neurogastroenterol Motil; 2014 Aug; 26(8):1087-94. PubMed ID: 24837493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of dextranomer in stabilised hyaluronic acid for treatment of faecal incontinence: a randomised, sham-controlled trial.
    Graf W; Mellgren A; Matzel KE; Hull T; Johansson C; Bernstein M;
    Lancet; 2011 Mar; 377(9770):997-1003. PubMed ID: 21420555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canine bladder tissue responses to injectable stabilized non-animal hyaluronic acid/dextranomer (NASHA/Dx) gel.
    Olson ME; Hjelm R
    Eur J Obstet Gynecol Reprod Biol; 2008 May; 138(1):114-5. PubMed ID: 17482338
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term efficacy of dextranomer in stabilized hyaluronic acid (NASHA/Dx) for treatment of faecal incontinence.
    La Torre F; de la Portilla F
    Colorectal Dis; 2013 May; 15(5):569-74. PubMed ID: 23374680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of stress urinary incontinence using a copolymer system: impact on quality of life.
    van Kerrebroeck P; ter Meulen F; Larsson G; Farrelly E; Edwall L; Fianu-Jonasson A
    BJU Int; 2004 Nov; 94(7):1040-3. PubMed ID: 15541124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urethral injection for stress urinary incontinence: long-term results with dextranomer/hyaluronic acid copolymer.
    Stenberg AM; Larsson G; Johnson P
    Int Urogynecol J Pelvic Floor Dysfunct; 2003 Nov; 14(5):335-8; discussion 338. PubMed ID: 14618311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and quality of life 2 years after treatment for faecal incontinence with injectable bulking agents.
    Danielson J; Karlbom U; Wester T; Graf W
    Tech Coloproctol; 2013 Aug; 17(4):389-95. PubMed ID: 23224913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Submucosal injection of stabilized nonanimal hyaluronic acid with dextranomer: a new treatment option for fecal incontinence.
    Danielson J; Karlbom U; Sonesson AC; Wester T; Graf W
    Dis Colon Rectum; 2009 Jun; 52(6):1101-6. PubMed ID: 19581853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-year cost-effectiveness model for non-animal stabilized hyaluronic acid and dextranomer copolymer compared with sacral nerve stimulation after conservative therapy for the management of fecal incontinence.
    Bernstein MA; Purdy CH; Becker A; Magar R
    Clin Ther; 2014 Jun; 36(6):890-905.e3. PubMed ID: 24815061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled multisite trial of injected bulking agents for women with intrinsic sphincter deficiency: mid-urethral injection of Zuidex via the Implacer versus proximal urethral injection of Contigen cystoscopically.
    Lightner D; Rovner E; Corcos J; Payne C; Brubaker L; Drutz H; Steinhoff G;
    Urology; 2009 Oct; 74(4):771-5. PubMed ID: 19660800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intraurethral injections of Zuidex: evaluation of the morbidity of the technique in the treatment of female urinary incontinence].
    Ferchaud J; Girard F; Ciofu C; Peyrat L; Haab F
    Prog Urol; 2005 Jun; 15(3):494-7. PubMed ID: 16097156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injectable bulking treatment of persistent fecal incontinence in adult patients after anorectal malformations.
    Danielson J; Karlbom U; Wester T; Graf W
    J Pediatr Surg; 2020 Mar; 55(3):397-402. PubMed ID: 31493885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Periurethral injections of dextranomer/hyaluronic acid copolymer in the treatment of female stress urinary incontinence: description of the technique and bibliographic review].
    Moreno Sierra J; Alonso Prieto MA; Fernández Montarroso L; Pérez Romero N; Hernández Sánchez E; Galante Romo I; Prieto Nogal S; Salinas Casado J; Silmi Moyano A
    Arch Esp Urol; 2006 Sep; 59(7):713-8. PubMed ID: 17078395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of polyacrylamide hydrogel for the treatment of female stress incontinence: a randomized, prospective, multicenter North American study.
    Sokol ER; Karram MM; Dmochowski R
    J Urol; 2014 Sep; 192(3):843-9. PubMed ID: 24704117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stress incontinence injection therapy: what is best for our patients?
    Chapple CR; Wein AJ; Brubaker L; Dmochowski R; Pons ME; Haab F; Hill S
    Eur Urol; 2005 Oct; 48(4):552-65. PubMed ID: 16118034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.